Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
Abstract
Patients requiring extracorporeal membrane oxygenation (ECMO) are at increased risk for blood stream infections, with about 13 percent attributable to fungal infections and fungemia is associated with a greater than 30 percent mortality. There is currently limited published data on fungemia in ECMO patients. Best practices for ECMO circuit management and antifungals are unknown with management often extrapolated from LVADs or other chronic indwelling devices. Presented are our experience with twelve cases of fungemia in eleven patients.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 22, 2022
- Accession Number
- AD1164306
Entities
People
- Joseph E. Marcus
- Melissa M Rosas
- Michal J. Sobieszczyk
- Phillip Mason
- Robert J. Walter
Organizations
- 59th Medical Wing